Applied DNA Sciences (NASDAQ:APDN – Get Free Report) and Rectitude (NASDAQ:RECT – Get Free Report) are both small-cap industrials companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation.
Profitability
This table compares Applied DNA Sciences and Rectitude’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Applied DNA Sciences | -399.91% | -136.17% | -101.95% |
Rectitude | N/A | N/A | N/A |
Volatility & Risk
Applied DNA Sciences has a beta of 0.15, suggesting that its share price is 85% less volatile than the S&P 500. Comparatively, Rectitude has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500.
Institutional and Insider Ownership
Analyst Ratings
This is a breakdown of recent recommendations for Applied DNA Sciences and Rectitude, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Applied DNA Sciences | 1 | 0 | 0 | 0 | 1.00 |
Rectitude | 1 | 0 | 0 | 0 | 1.00 |
Earnings and Valuation
This table compares Applied DNA Sciences and Rectitude”s top-line revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Applied DNA Sciences | $3.74 million | 2.12 | -$6.99 million | ($923.81) | -0.01 |
Rectitude | $43.80 million | 1.23 | $1.66 million | N/A | N/A |
Rectitude has higher revenue and earnings than Applied DNA Sciences.
Summary
Rectitude beats Applied DNA Sciences on 6 of the 9 factors compared between the two stocks.
About Applied DNA Sciences
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
About Rectitude
Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, gloves, safety footwear, personal fall arrest systems, portable fire extinguishers and traffic products. The Company also offers auxiliary products such as industrial hardware tools and electrical hardware required for construction sites. Rectitude Holdings Ltd is based in SINGAPORE.
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.